The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
2020/09/01 by George A. Keepers, Laura J. Fochtmann, Joan M. Anzia +12 · 34 citations
Medicine · Arts and Humanities · Psychology · #Schizophrenia research and treatment #Mental Health and Psychiatry #Mental Health Treatment and Access
paper · pdf · doi:10.1176/appi.ajp.2020.177901
Abstract
V Resumen
Citations
Cited by
- Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of life
- Acceptance and Commitment Therapy for Psychosis
- Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia
- Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia
- COVID-19-associated psychosis: A systematic review of case reports
- How Can We Better Assist Caregivers With Understanding and Addressing the Cognitive Health Needs of People With Psychotic Disorders?
- Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia
- Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics
- Effects of mindfulness- and acceptance-based interventions for individuals with schizophrenia spectrum disorders: A systematic meta-review
- A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors. [europepmc]
- The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. [europepmc]
- Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials. [europepmc]
- Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis. [europepmc]
- Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations. [europepmc]
- Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia. [europepmc]
- Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines? [europepmc]
- COVID-19-associated psychosis: A systematic review of case reports. [europepmc]
- Antipsychotic medication for women with schizophrenia spectrum disorders. [europepmc]
- Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. [europepmc]
- Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians. [europepmc]
- Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy? [europepmc]
- Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials. [europepmc]
- An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders. [europepmc]
- Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art. [europepmc]
- Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia. [europepmc]
- Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics. [europepmc]
- Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects. [europepmc]
- The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum. [europepmc]
- Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study. [europepmc]
- The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression. [europepmc]
- Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development. [europepmc]
- A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia. [europepmc]
- Thinking About the Future of Cognitive Remediation Therapy Revisited: What Is Left to Solve Before Patients Have Access? [europepmc]
- Neuroimaging for precision medicine in psychiatry. [europepmc]
Related